Pharmaceutical giant Cencora disclosed a cyberattack where data was stolen from its corporate IT systems. The breach was reported in a Form 8-K filing with the SEC. Following the disclosure, Cencora initiated collaboration with law enforcement and cybersecurity experts to investigate the incident. While containment measures have been implemented, the full extent of the breach’s impact on Cencora’s finances and operations remains uncertain.
Cencora, previously known as AmerisourceBergen, specializes in pharmaceutical services, providing drug distribution and solutions for various healthcare sectors. The company had $262.2 billion in revenue for fiscal year 2023 and employs approximately 46,000 people. Despite its substantial size and revenue, Cencora was not immune to cyber threats, as evidenced by the recent attack on its IT systems.
Upon initial detection of the unauthorized activity, Cencora took immediate containment steps and commenced an investigation with the assistance of law enforcement, cybersecurity experts, and external counsel. The company’s swift response highlights the seriousness with which it regards cybersecurity incidents, prioritizing collaboration and thorough investigation to address potential vulnerabilities and safeguard sensitive data.
